Sidley has advised Opus Genetics on the deal. Opus Genetics, Inc., a clinical-stage gene therapy company focused on inherited retinal diseases, has entered into a strategic...
Opus Genetics Secures $155 Million Structured Financing from Oberland Capital
ADVANZ PHARMA’s €1.08 Billion Refinancing
Sidley Austin represented ADVANZ PHARMA on the transaction. ADVANZ PHARMA, a Nordic Capital portfolio company, announced the issuance of €917 million (equivalent) in new euro- and...
Jefferies Finance’s $1.95 Billion Bank and Bond Financing
Sidley Austin represented Jefferies Finance LLC in the transaction. Jefferies Finance LLC, as borrower and issuer, announced its US$1.95 billion bank/bond financing, consisting of a US$950...